Key Takeaways
- • Arintra raised $25 million in Series B funding, bringing total capitalization to $51 million, with Define Ventures leading the round and participation from Peak XV Partners, Y Combinator, Endeavor Health Ventures, and other existing backers.
- • The company operates as an enterprise AI platform for healthcare revenue assurance, deploying autonomous medical coding across 23+ specialties and multiple care settings, with integrated denial appeals and clinical documentation intelligence capabilities.
- • Arintra has secured integration into two major health IT ecosystems: Epic's Toolbox and the athenahealth Marketplace, alongside HITRUST e1 certification and a 93/100 A+ rating from KLAS Research, signaling institutional-grade credibility and interoperability.
- • The platform is deployed across seven named enterprise health systems (UC Davis Health, Mercyhealth, Meritus Health, Rochester Regional Health, Reid Health, Mercy Medical Center, and others), with Endeavor Health participating in both Series A and Series B rounds, indicating strong clinical validation.
- • Arintra positions itself as the first enterprise AI platform purpose-built for healthcare revenue assurance, addressing a critical operational inefficiency in health systems' billing and payment cycles.
Summary
Arintra announced a $25 million Series B funding round on August 28, 2026, led by Define Ventures with participation from an investor consortium including Peak XV Partners, Yale New Haven Health Center for Health Care Innovation, Endeavor Health Ventures, Y Combinator, Counterpart Ventures, Ten13, and Spider Capital. The round brings the company's total funding to $51 million, establishing significant institutional backing for its healthcare AI platform.
The company describes itself as the first enterprise AI platform dedicated to revenue assurance in healthcare, leveraging agentic artificial intelligence combined with clinical domain expertise. Arintra's core functionality centers on autonomous medical coding across 23 or more specialties and across every care setting operated by health systems, with downstream cascading capabilities including clinical documentation intelligence (CDI) and denial appeals management. The platform is designed to enable health systems to achieve accurate, timely, and equitable payment processing across their revenue cycles.
Arintra's market traction is evidenced by deployment across named enterprise health systems including UC Davis Health, Mercyhealth, Meritus Health, Rochester Regional Health, Reid Health, and Mercy Medical Center. The company has achieved notable certifications and validation metrics, including HITRUST e1 certification and a 93/100 performance rating with an A+ grade from KLAS Research. Integration into major health IT vendor ecosystems—specifically Epic's Toolbox and athenahealth's Marketplace—positions the platform within the standard vendor infrastructure that enterprise health systems rely on for interoperability.
Notably, Endeavor Health, a Chicagoland-based health system, participated in both Arintra's Series A and Series B funding rounds, suggesting sustained confidence in the technology's clinical utility and operational value. The repeat participation from existing investors, combined with new institutional backing from Define Ventures, reflects strong signal alignment on the market opportunity in healthcare revenue cycle automation.
The company describes itself as the first enterprise AI platform dedicated to revenue assurance in healthcare, leveraging agentic artificial intelligence combined with clinical domain expertise. Arintra's core functionality centers on autonomous medical coding across 23 or more specialties and across every care setting operated by health systems, with downstream cascading capabilities including clinical documentation intelligence (CDI) and denial appeals management. The platform is designed to enable health systems to achieve accurate, timely, and equitable payment processing across their revenue cycles.
Arintra's market traction is evidenced by deployment across named enterprise health systems including UC Davis Health, Mercyhealth, Meritus Health, Rochester Regional Health, Reid Health, and Mercy Medical Center. The company has achieved notable certifications and validation metrics, including HITRUST e1 certification and a 93/100 performance rating with an A+ grade from KLAS Research. Integration into major health IT vendor ecosystems—specifically Epic's Toolbox and athenahealth's Marketplace—positions the platform within the standard vendor infrastructure that enterprise health systems rely on for interoperability.
Notably, Endeavor Health, a Chicagoland-based health system, participated in both Arintra's Series A and Series B funding rounds, suggesting sustained confidence in the technology's clinical utility and operational value. The repeat participation from existing investors, combined with new institutional backing from Define Ventures, reflects strong signal alignment on the market opportunity in healthcare revenue cycle automation.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.